Conversely, in pancreatic ductal adenocarcinoma (PDAC) [19], colorectal cancer (CRC) [20], and gastric cancer (GC) [21], Dectin-1 signaling activation is associated with the suppression of adaptive immunity and tumor progression. The gene discussed is CLEC7A; the disease is pancreatic ductal adenocarcinoma.